Outcome Reduction With Initial Glargine Intervention - ORIGIN Basal Insulin


This trial sought to study if early normalization of fasting glucose levels by early provision of basal insulin in patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or early type 2 diabetes mellitus (DM) would be associated with improved cardiovascular (CV) outcomes.